Macro Group eyes EGP 1B sales in 2023

Updated 4/10/2023 11:41:00 AM
Macro Group eyes EGP 1B sales in 2023

Arab Finance: Macro Group Pharmaceutical (Macro Capital) announced that it is targeting sales of EGP 1 billion in 2023 by maintaining the 25-30% expected growth rate this year, as per a filing on April 10th.

The company posted a 17.51% year-on-year (YoY) increase in its consolidated net profits after tax and non-controlling interests during the full year ended December 31st 2022.

Founded in 2002, Macro Group is a leading Egyptian cosmeceutical company based in Cairo.

 

Related News